MindBio Therapeutics CEO Discusses AI Voice Detection Platform on TechMediaWire Podcast

MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Founder and CEO Justin Hanka recently appeared on the TechMediaWire Podcast to discuss the company’s artificial intelligence-driven voice analysis technology, which aims to detect drug and alcohol intoxication through noninvasive speech analysis. The technology addresses limitations of traditional testing methods and is being commercialized for regulated workplace environments such as mining, where real-time intoxication screening could significantly improve safety.

During the podcast, Hanka explained that MindBio’s AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy solely through voice analysis. The company is developing an enterprise platform that includes Edge-AI kiosks integrating bespoke hardware and software for detection in various industries, including mining, aviation, construction, and law enforcement. This approach offers a scalable and noninvasive alternative to current methods like breathalyzers and urine tests, which can be intrusive and time-consuming.

The implications of this technology extend beyond workplace safety. By enabling rapid, noninvasive testing, MindBio’s platform could help reduce accidents and fatalities caused by impaired workers. In mining, where heavy machinery operation requires high alertness, real-time monitoring could prevent incidents that endanger lives and disrupt operations. Similarly, in aviation and construction, where safety regulations are stringent, such technology could become a standard tool for compliance and risk management.

Investors and industry watchers may find the company’s progress noteworthy. The full interview is available at https://ibn.fm/SU3Ay. For more information on MindBio Therapeutics, including recent news and updates, visit the company’s newsroom at https://ibn.fm/MBQIF.

The development of AI-based voice analysis for intoxication detection represents a shift from traditional methods, offering potential for broader adoption in safety-critical sectors. As the technology matures, it could also find applications in law enforcement and other areas where rapid, reliable testing is needed. MindBio’s focus on regulated industries positions it to address a clear market need, but the company faces challenges in proving accuracy across diverse populations and ensuring privacy compliance.

Overall, the podcast discussion underscores the growing role of AI in workplace safety and the potential for noninvasive technologies to replace existing testing regimes. While still in early stages, MindBio’s platform could set a new standard for intoxication detection if successfully deployed.

This news story relied on content distributed by InvestorBrandNetwork (IBN). Blockchain Registration, Verification & Enhancement provided by NewsRamp. The source URL for this press release is MindBio Therapeutics CEO Discusses AI Voice Detection Platform on TechMediaWire Podcast.

The post MindBio Therapeutics CEO Discusses AI Voice Detection Platform on TechMediaWire Podcast appeared first on citybuzz.